Endothelial dysfunction by brachial artery flow-mediated dilatation as predictor of major adverse cardiovascular event in acute coronary syndrome

https://doi.org/10.53730/ijhs.v6nS9.12263

Authors

  • Bunga Novitalia Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Airlangga– Dr. Soetomo General Hospital, Surabaya, East Java, Indonesia
  • I Gde Rurus Suryawan Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Airlangga– Dr. Soetomo General Hospital, Surabaya, East Java, Indonesia
  • Agus Subagjo Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Airlangga– Dr. Soetomo General Hospital, Surabaya, East Java, Indonesia
  • Muhammad Firdani Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Airlangga– Dr. Soetomo General Hospital, Surabaya, East Java, Indonesia
  • Ryan Enast Intan Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Airlangga– Dr. Soetomo General Hospital, Surabaya, East Java, Indonesia

Keywords:

acute coronary syndrome, flow-mediated dilatation, endothelial dysfunction, major adverse cardiovascular event

Abstract

Endothelial dysfunction (ED) is the earliest marker in the process of atherosclerosis formation and is thought to be a risk predictor of acute coronary syndrome    (ACS) outcome. Our aim is to analyse the ED by brachial artery flow-mediated dilatation (FMD) as a predictor of major adverse cardiovascular event (MACE) in ACS patients. This is a prospective cohort study with consecutive sampling for ACS in a hospital at Indonesia in April-May, 2021. 69 patients who met the inclusion were examined for brachial artery FMD with value <5% stated as ED. MACE was observed during in-hospital, 1 month, and 6 months after hospitalization, and analysed using bivariate analysis and multivariate logistic regression analysis. From bivariate analysis, significant result was found for FMD <5% (RR 7,13; 95%CI=2,07-24,58; p=0.001) with 1 month of follow-up MACE and diabetes mellitus (RR 2,57; 95%CI=1,15-5,73; p=0,043) and FMD <5% (RR=5,60; 95%CI=2,44-12,86; p<0.001) with 6 months of follow-up MACE. In multivariate analysis, FMD <5% was found as the most significant predictor of 1 month and 6 months follow-up MACE. ED by brachial artery FMD was an important independent predictor of the   MACE during 1 month and 6 months follow-up after ACS and might be useful for risk stratification outcome.

Downloads

Download data is not yet available.

References

Anderson, T. J., Charbonneau, F., Title, L. M., Buithieu, J., Rose, M. S., Conradson, H., Hildebrand, K., Fung, M., Verma, S., & Lonn, E. M. (2011). Microvascular function predicts cardiovascular events in primary prevention: long-term results from the Firefighters and Their Endothelium (FATE) study. Circulation, 123(2), 163–169. https://doi.org/10.1161/CIRCULATIONAHA.110.953653

Celermajer, D. S., Sorensen, K. E., Gooch, V. M., Miller, 0. 1., Sullivan, I. D., Lloyd, J. K., Deanfield, J. E., & Spiegelhalter, D. J. (1992). Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. The Lancet, 340(8828), 1111–1115. https://doi.org/10.1016/0140-6736(92)93147-F

Collet, J.-P., Thiele, H., Barbato, E., Barthélémy, O., Bauersachs, J., Bhatt, D. L., Dendale, P., Dorobantu, M., Edvardsen, T., Folliguet, T., Gale, C. P., Gilard, M., Jobs, A., Jüni, P., Lambrinou, E., Lewis, B. S., Mehilli, J., Meliga, E., Merkely, B., … Siontis, G. C. M. (2021). 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. European Heart Journal, 42(14), 1289–1367. https://doi.org/10.1093/eurheartj/ehaa575

Fichtlscherer, S., Breuer, S., & Zeiher, A. M. (2004). Prognostic Value of Systemic Endothelial Dysfunction in Patients With Acute Coronary Syndromes. Circulation, 110(14), 1926–1932. https://doi.org/10.1161/01.CIR.0000143378.58099.8C

García, E. N., Balaguer, J., Jiménez, E., Lledó, A. G., Caballero, M., & Chaparro, M. (2003). Analysis of Differences in Flow-Mediated Dilation in Relation to the Treatment of Coronary Patients. 56(February 2002), 36–44.

Green, D. J., Jones, H., Thijssen, D., Cable, N. T., & Atkinson, G. (2011). Flow-mediated dilation and cardiovascular event prediction: Does nitric oxide matter? Hypertension, 57(3), 363–369. https://doi.org/10.1161/HYPERTENSIONAHA.110.167015

Hamburg, N. M., Larson, M. G., Vita, J. A., Vasan, R. S., Keyes, M. J., Widlansky, M. E., Fox, C. S., Mitchell, G. F., Levy, D., Meigs, J. B., & Benjamin, E. J. (2008). Metabolic Syndrome, Insulin Resistance, and Brachial Artery Vasodilator Function in Framingham Offspring Participants Without Clinical Evidence of Cardiovascular Disease. The American Journal of Cardiology, 101(1), 82–88. https://doi.org/10.1016/j.amjcard.2007.07.053

Harris, R. A., Nishiyama, S. K., Wray, D. W., & Richardson, R. S. (2010a). Ultrasound assessment of flow-mediated dilation. Hypertension, 55(5), 1075–1085. https://doi.org/10.1161/HYPERTENSIONAHA.110.150821

Harris, R. A., Nishiyama, S. K., Wray, D. W., & Richardson, R. S. (2010b). Ultrasound assessment of flow-mediated dilation. Hypertension (Dallas, Tex. : 1979), 55(5), 1075–1085. https://doi.org/10.1161/HYPERTENSIONAHA.110.150821

Ibanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., Caforio, A. L. P., Crea, F., Goudevenos, J. A., Halvorsen, S., Hindricks, G., Kastrati, A., Lenzen, M. J., Prescott, E., Roffi, M., Valgimigli, M., Varenhorst, C., Vranckx, P., & Widimský, P. (2018). 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Soci. European Heart Journal, 39(2), 119–177. https://doi.org/10.1093/eurheartj/ehx393

Inaba, Y., Chen, J. A., & Bergmann, S. R. (2010). Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: A meta-analysis. International Journal of Cardiovascular Imaging, 26(6), 631–640. https://doi.org/10.1007/s10554-010-9616-1

Kacprzak, M., & Zielinska, M. (2016). Prognostic value of myeloperoxidase concentration in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. International Journal of Cardiology, 223, 452–457. https://doi.org/10.1016/j.ijcard.2016.07.258

Kallio, K., Jokinen, E., Raitakari, O. T., Hämäläinen, M., Siltala, M., Volanen, I., Kaitosaari, T., Viikari, J., Rönnemaa, T., & Simell, O. (2007). Tobacco Smoke Exposure Is Associated With Attenuated Endothelial Function in 11-Year-Old Healthy Children. Circulation, 115(25), 3205–3212. https://doi.org/10.1161/CIRCULATIONAHA.106.674804

Khidoyatova, M. R., Kayumov, U. K., Inoyatova, F. K., Fozilov, K. G., Khamidullaeva, G. A., & Eshpulatov, A. S. (2022). Clinical status of patients with coronary artery disease post COVID-19. International Journal of Health & Medical Sciences, 5(1), 137-144. https://doi.org/10.21744/ijhms.v5n1.1858

Kitta, Y., Obata, J. ei, Nakamura, T., Hirano, M., Kodama, Y., Fujioka, D., Saito, Y., Kawabata, K. ichi, Sano, K., Kobayashi, T., Yano, T., Nakamura, K., & Kugiyama, K. (2009). Persistent Impairment of Endothelial Vasomotor Function Has a Negative Impact on Outcome in Patients With Coronary Artery Disease. Journal of the American College of Cardiology, 53(4), 323–330. https://doi.org/10.1016/j.jacc.2008.08.074

Lerman, A., & Zeiher, A. M. (2005). Endothelial Function. Circulation, 111(3), 363–368. https://doi.org/10.1161/01.CIR.0000153339.27064.14

Lind, L., Berglund, L., Larsson, A., & Sundström, J. (2011). Endothelial function in resistance and conduit arteries and 5-year risk of cardiovascular disease. Circulation, 123(14), 1545–1551. https://doi.org/10.1161/CIRCULATIONAHA.110.984047

Lundberg, J. O., Gladwin, M. T., & Weitzberg, E. (2015). Strategies to increase nitric oxide signalling in cardiovascular disease. Nature Reviews Drug Discovery, 14(9), 623–641. https://doi.org/10.1038/nrd4623

Madan, P., Elayda, M. A., Lee, V. V., & Wilson, J. M. (2008). Predicting major adverse cardiac events after percutaneous coronary intervention: The Texas Heart Institute risk score. American Heart Journal, 155(6), 1068–1074. https://doi.org/10.1016/j.ahj.2008.01.034

Matsuzawa, Y., Guddeti, R. R., Kwon, T.-G., Lerman, L. O., & Lerman, A. (2015). Secondary Prevention Strategy of Cardiovascular Disease Using Endothelial Function Testing. Circulation Journal, 79(4), 685–694. https://doi.org/10.1253/circj.CJ-15-0068

Matsuzawa, Y., Kwon, T. G., Lennon, R. J., Lerman, L. O., & Lerman, A. (2015). Prognostic value of flow-mediated vasodilation in brachial artery and fingertip artery for cardiovascular events: A systematic review and meta-analysis. Journal of the American Heart Association, 4(11), 1–15. https://doi.org/10.1161/JAHA.115.002270

Modena, M. G., Bonetti, L., Coppi, F., Bursi, F., & Rossi, R. (2002). Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. Journal of the American College of Cardiology, 40(3), 505–510. https://doi.org/10.1016/S0735-1097(02)01976-9

Naghavi, M., Libby, P., Falk, E., Casscells, S. W., Litovsky, S., Rumberger, J., Badimon, J. J., Stefanadis, C., Moreno, P., Pasterkamp, G., Fayad, Z., Stone, P. H., Waxman, S., Raggi, P., Madjid, M., Zarrabi, A., Burke, A., Yuan, C., Fitzgerald, P. J., … Willerson, J. T. (2003). From Vulnerable Plaque to Vulnerable Patient. Circulation, 108(14), 1664–1672. https://doi.org/10.1161/01.CIR.0000087480.94275.97

Napoli, C., de Nigris, F., Williams-Ignarro, S., Pignalosa, O., Sica, V., & Ignarro, L. J. (2006). Nitric oxide and atherosclerosis: an update. Nitric Oxide : Biology and Chemistry, 15(4), 265–279. https://doi.org/10.1016/j.niox.2006.03.011

Park, K.-H., & Park, W. J. (2015). Endothelial Dysfunction: Clinical Implications in Cardiovascular Disease and Therapeutic Approaches. Journal of Korean Medical Science, 30(9), 1213. https://doi.org/10.3346/jkms.2015.30.9.1213

Poudel, I., Tejpal, C., Rashid, H., & Jahan, N. (2019). Major Adverse Cardiovascular Events: An Inevitable Outcome of ST-elevation myocardial infarction? A Literature Review. Cureus, 11(7). https://doi.org/10.7759/cureus.5280

Ras, R. T., Streppel, M. T., Draijer, R., & Zock, P. L. (2013). Flow-mediated dilation and cardiovascular risk prediction: A systematic review with meta-analysis. International Journal of Cardiology, 168(1), 344–351. https://doi.org/10.1016/j.ijcard.2012.09.047

Sawada, T., Emoto, T., Motoji, Y., Hashimoto, M., Kageyama, H., Terashita, D., Mizoguchi, T., Mizuguchi, T., Iwasaki, M., Taira, K., Okamoto, H., Matsuo, Y., Kim, S. K., Takarada, A., & Yokoyama, M. (2013). Possible association between non-invasive parameter of flow-mediated dilatation in brachial artery and whole coronary plaque vulnerability in patients with coronary artery disease. International Journal of Cardiology, 166(3), 613–620. https://doi.org/10.1016/j.ijcard.2011.11.101

Shimbo, D., Grahame-Clarke, C., Miyake, Y., Rodriguez, C., Sciacca, R., Di Tullio, M., Boden-Albala, B., Sacco, R., & Homma, S. (2007). The association between endothelial dysfunction and cardiovascular outcomes in a population-based multi-ethnic cohort. Atherosclerosis, 192(1), 197–203. https://doi.org/10.1016/j.atherosclerosis.2006.05.005

Stewart, J., Manmathan, G., & Wilkinson, P. (2017). Primary prevention of cardiovascular disease: A review of contemporary guidance and literature. JRSM Cardiovascular Disease, 6, 204800401668721. https://doi.org/10.1177/2048004016687211

Strisciuglio, T., De Luca, S., Capuano, E., Luciano, R., Niglio, T., Trimarco, B., & Galasso, G. (2014). Endothelial Dysfunction: Its Clinical Value and Methods of Assessment. Current Atherosclerosis Reports, 16(6), 417. https://doi.org/10.1007/s11883-014-0417-1

Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Get vaccinated when it is your turn and follow the local guidelines. International Journal of Health Sciences, 5(3), x-xv. https://doi.org/10.53730/ijhs.v5n3.2938

Takishima, I., Nakamura, T., Hirano, M., Kitta, Y., Kobayashi, T., Fujioka, D., Saito, Y., Watanabe, K., Watanabe, Y., Mishina, H., Obata, J., Kawabata, K., Tamaru, S., & Kugiyama, K. (2012). Predictive value of serial assessment of endothelial function in chronic heart failure. International Journal of Cardiology, 158(3), 417–422. https://doi.org/10.1016/j.ijcard.2011.01.059

Tanaka, S., Sanuki, Y., Ozumi, K., Harada, T., & Tasaki, H. (2018). Heart failure with preserved vs reduced ejection fraction following cardiac rehabilitation: impact of endothelial function. Heart and Vessels, 33(8), 886–892. https://doi.org/10.1007/s00380-018-1128-2

Thijssen, D. H. J., Black, M. A., Pyke, K. E., Padilla, J., Atkinson, G., Harris, R. A., Parker, B., Widlansky, M. E., Tschakovsky, M. E., & Green, D. J. (2011). Assessment of flow-mediated dilation in humans: A methodological and physiological guideline. American Journal of Physiology - Heart and Circulatory Physiology, 300(1), 2–13. https://doi.org/10.1152/ajpheart.00471.2010

Thygesen, K., Alpert, J. S., Jaffe, A. S., Chaitman, B. R., Bax, J. J., Morrow, D. A., & White, H. D. (2018). Fourth Universal Definition of Myocardial Infarction (2018). Journal of the American College of Cardiology, 72(18), 2231–2264. https://doi.org/10.1016/j.jacc.2018.08.1038

Tian, L., Wei, C., Zhu, J., Liu, L., Liang, Y., Li, J., & Yang, Y. (2013). Newly diagnosed and previously known diabetes mellitus and short-term outcomes in patients with acute myocardial infarction. Coronary Artery Disease, 24(8), 669–675. https://doi.org/10.1097/MCA.0000000000000036

Tsai, I. T., Wang, C. P., Lu, Y. C., Hung, W. C., Wu, C. C., Lu, L. F., Chung, F. M., Hsu, C. C., Lee, Y. J., & Yu, T. H. (2017). The burden of major adverse cardiac events in patients with coronary artery disease. BMC Cardiovascular Disorders, 17(1), 1–13. https://doi.org/10.1186/s12872-016-0436-7

Vita, J. A., & Keaney, J. F. (2002). Endothelial Function. Circulation, 106(6), 640–642. https://doi.org/10.1161/01.CIR.0000028581.07992.56

Wagner, D. D., & Frenette, P. S. (2008). The vessel wall and its interactions. Blood, 111(11), 5271–5281. https://doi.org/10.1182/blood-2008-01-078204

Wang, X., Guo, F., Li, G., Cao, Y., & Fu, H. (2009). Prognostic role of brachial reactivity in patients with ST myocardial infarction after percutaneous coronary intervention. Coronary Artery Disease, 20(7), 467–472. https://doi.org/10.1097/MCA.0b013e32832e5c61

WorldHealthOrganization. (2018). NCDs Country Profiles 2018 WHO. 224.

Xu, L., Yu, C., Jiang, J., Zheng, H., Yao, S., Pei, L., Sun, L., Xue, F., & Huang, Y. (2015). Major adverse cardiac events in elderly patients with coronary artery disease undergoing noncardiac surgery: A multicenter prospective study in China. Archives of Gerontology and Geriatrics, 61(3), 503–509. https://doi.org/10.1016/j.archger.2015.07.006

Yamaoka-Tojo, M. (2017). Endothelial Function for Cardiovascular Disease Prevention and Management. International Journal of Clinical Cardiology, 4(3), 1–11. https://doi.org/10.23937/2378-2951/1410103

Yeboah, J., Folsom, A. R., Burke, G. L., Johnson, C., Polak, J. F., Post, W., Lima, J. A., Crouse, J. R., & Herrington, D. M. (2009). Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: The multi-ethnic study of atherosclerosis. Circulation, 120(6), 502–509. https://doi.org/10.1161/CIRCULATIONAHA.109.864801

Published

29-08-2022

How to Cite

Novitalia, B., Suryawan, I. G. R., Subagjo, A., Firdani, M., & Intan, R. E. (2022). Endothelial dysfunction by brachial artery flow-mediated dilatation as predictor of major adverse cardiovascular event in acute coronary syndrome. International Journal of Health Sciences, 6(S9), 336–353. https://doi.org/10.53730/ijhs.v6nS9.12263

Issue

Section

Peer Review Articles